Additionally, we observed that treatment with PcP extract alleviated pyroptosis in rats with NAFLD, as evidenced by a reduction in caspase‐1 activity and NLRP3, GSDMD/N, IL‐1β, and IL‐18 levels. Here, GSDMD is linked to metabolic dysfunction-associated steatotic liver disease.